Entrada Therapeutics Reports Third Quarter 2021 Financial Results

Go back to Entrada Therapeutics Reports Third Quarter 2021 Financial Results
(NASDAQ: TRDA) Delayed: 7.60 -0.18 (2.31%)
Previous Close $7.78    52 Week High
Open $7.76    52 Week Low
Day High $7.77    P/E N/A 
Day Low $7.30    EPS
Volume 250,040